Skip to Content
Biotechnology

China is already gene-editing a lot of humans

January 22, 2018

A new report says at least 86 people have had their genes edited in China to help cure disease.

Backstory: We already knew that China had experimented with CRISPR gene editing in humans since 2016, becoming the first nation in the world to do so. But no human CRISPR trials have so far taken place in America.

What’s new: An investigation by the Wall Street Journal says that CRISPR gene editing has actually been used in Chinese hospitals to treat human diseases like cancer since 2015. The new report shows the extent of the trend.

How it’s possible: Unlike the US, China allows a hospital’s ethics committee to approve research on humans. CRISPR trials can be approved within an afternoon.

But: The push to use the technique isn’t necessarily a good idea. There are still safety concerns about such treatments, from immune reactions to unintended edits.

Deep Dive

Biotechnology

This startup wants to copy you into an embryo for organ harvesting

With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics.

This nanoparticle could be the key to a universal covid vaccine

Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.

How do strong muscles keep your brain healthy?

There’s a robust molecular language being spoken between your muscles and your brain.

The quest to show that biological sex matters in the immune system

A handful of immunologists are pushing the field to take attributes such as sex chromosomes, sex hormones, and reproductive tissues into account.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.